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ABSTRACT
Objective: To minimise the intake of industrially
produced trans fat (I-TF) and thereby decrease the risk
of coronary heart disease (CHD), nearly all European
countries rely on food producers to voluntarily reduce
the I-TF content in food. The objective of this study
was to monitor the change in presence of I-TF in
biscuits/cakes/wafers in six countries in South-eastern
Europe from 2012 to 2014, including two members of
the European Union (Slovenia and Croatia).
Design: Three large supermarkets were visited in each
of the six capitals in 2012. Pre-packaged biscuits/
cakes/wafers were bought if the products contained
more than 15 g of total fat per 100 g of product and if
partially hydrogenated oil or a similar term was
disclosed at the beginning of the ingredients list. These
same supermarkets were revisited in 2014 and the
same collection procedure was followed. All foods were
subsequently analysed for total fat and trans fat in the
same laboratory.
Results: The number of packages bought in the six
countries taken together was 266 in 2012 and 643 in
2014. Some were identical, and therefore only 226
were analysed in 2012 and 434 in 2014. Packages with
less than 2% of fat from I-TF went up from 69 to 235,
while products with more than 2% (illegal in Denmark)
doubled from an average of 33 to an average of 68
products for the six countries, with considerable
variation across countries. The per cent of I-TF in total
fat decreased slightly, from a mean (SD) of 22 (13) in
2012 to 18 (9) in 2014.
Conclusions: The findings suggest that voluntary
reduction of I-TF in foods with high amounts is an
ineffective strategy in several European countries.
Alternative strategies both within and outside the
European Union are necessary to protect all subgroups
of the populations against an increased risk of CHD.
INTRODUCTION
High amounts of trans fat (TF) in food ori-
ginate from the industrial hydrogenation of
oils. Compared to non-hydrogenated oils,
fats containing industrially produced trans fat
(I-TF) are solid at room temperature, have
some technical advantages for food process-
ing, and prolong the shelf life of products.
A meta-analysis of four large prospective
studies found that an average intake of
approximately 5 g/day of TF, corresponding
to 2% of the total energy intake, was asso-
ciated with a 23% increase in the risk of cor-
onary heart disease (CHD).1 More recently,
I-TF intake was associated with all-cause mor-
tality in a large US-based study.2 A 2013
review concluded that ‘the detrimental
effects of industrial trans fatty acids on heart
health are beyond dispute’.3
On the basis of the relationship between the
intake of I-TF and CHD, several public health
organisations, as well as the WHO in 2006,
have recommended for years that I-TF intake
be lowered as much as possible. More recently,
the European Society of Cardiology (ESC)
and European Association of Rehabilitation
and Prevention have also recommended a
legislative limit on I-TF in foods.4 In the USA,
by a ﬁnal determination, the Food and Drug
Administration FDA recently revoked the pre-
vious Generally Recognized As Safe (GRAS)
status of partially hydrogenated oils—a step
Strengths and limitations of this study
▪ A strength of this study is that the same proced-
ure to obtain popular foods found in large super-
markets in European capitals in 2012 was
followed in the same supermarkets in 2014, and
products were analysed for industrially produced
trans fat (I-TF) in the same laboratory.
▪ A limitation is that the average daily intake of
I-TF was not measured in any subgroup of the
population, but instead was inferred from the
availability of popular foods with high amounts
of I-TF in large supermarkets.
▪ Another limitation is that no other food groups
(such as shortenings and margarines) and no
unpackaged foods (such as baked goods, sweet
rolls, pastries and buns) were investigated.
Further, biscuits/cakes/wafers that did not have
the words partially hydrogenated fats or similar
terms in the list of ingredients were not
investigated.
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that led the ESC to call on European policymakers to
introduce a legislative limit on I-TF in foods.5 6
In 2003, Denmark introduced a legislative sales ban
aimed at the ﬁnal consumer, limiting the I-TF content in
the total fat of foods to a maximum of 2%. The legislation
applies to locally produced as well as imported foods. In
2009, Austria and Switzerland introduced a legislative
ban similar to the Danish ban, followed by Iceland in
2011, Hungary and Norway in 2014 and Latvia starting in
2016. However, currently, only a minority of the popula-
tion in Europe (less than 50 million of the 500 million
people in the European Union) and none of the popula-
tion of most neighbouring countries are protected by
legislation that makes it illegal to sell foods with high
amounts of I-TF. One argument against a legislative limit
in some large European countries is that I-TF is already
gradually disappearing due to voluntary reductions by
the food producers. The purpose of the present study
was to investigate to what extent this was the case in a
number of countries that previously sold many popular
products with high amounts of I-TF. The availability of
many different prepackaged biscuits/cakes/wafers with
high amounts of I-TF in large supermarkets in six coun-
tries in South-eastern Europe was observed in 2012.7 In
this study, the changes in availability of this type of food
from 2012 to 2014 were investigated.
METHODS
Purchase of biscuits/cakes/wafers in supermarkets
The six countries visited encompass Slovenia, Croatia,
Serbia, Bosnia and Herzegovina, Montenegro and the
Former Yugoslav Republic of Macedonia (FYROM). In
2012, we asked the main tourist ofﬁce in the capital of
each country to identify three large supermarkets, pref-
erably chain supermarkets with many large shops across
the country. The same stores were visited in 2014.
Prepackaged biscuits/cakes/wafers were chosen because
they are frequently consumed and are easily accessible.
Furthermore, these foods traditionally contain I-TF-rich,
partially hydrogenated vegetable oils as their major lipid
ingredient and I-TF has previously been found in high
concentrations in Serbian biscuits.8 The packages of bis-
cuits/cakes/wafers were obtained by systematically exam-
ining the labels of the products placed on the
appropriate shelves in the supermarkets. Packages were
purchased if they met the following criteria:
▸ ‘Partially hydrogenated fat’ or a similar term was
listed among the ﬁrst 4 on the list of ingredients
(which are ranked according to content). Packages
with the term ‘unhydrogenated fat’ or ‘fully hydroge-
nated fat’ were not purchased.
▸ Total fat content was equal to or exceeded 15 g per
100 g of product. High fat foods are generally
deﬁned as containing more than 15–20 g of total fat
per 100 g of food.
If the same product appeared in packages of different
sizes, only the smallest size was bought. If the same
package with the same barcode ID number was found in
two different supermarkets in the same capital, only the
one with the most distant ‘best before’ date was included
in the study. Each package was subsequently labelled,
and duplicate samples were taken for analysis. The
barcode number, the name of the producer, the country
of origin and the ‘best before’ date were all registered
and the empty packages were stored. In the occasional
event that the food producers had two consecutive
names, we allocated only the ﬁrst name to the food.
Analysis of TF
The foods were homogenised, and the fatty acid content
was analysed using gas chromatography on a 60 m highly
polar capillary column using a modiﬁcation of the
AOAC 00606 method. All analytical work on samples
obtained in 2012 and in 2014 was conducted by
Microbac Laboratories in Warrendale, Pennsylvania,
USA, an ISO-17025-certiﬁed laboratory. The measure-
ment cannot distinguish I-TF from ruminant TF. If
butter as a ruminant fat has been used in the product in
addition to partially hydrogenated vegetable oil, some of
the TF in the product may be derived from butter that
on average contains a few per cent of the fat as TF. In
this paper, the term I-TF is used in spite of the fact that
a minor part may be TF derived from ruminant fat.
RESULTS
Products
The number of packages bought in the six countries
taken together was 266 in 2012 and 643 in 2014. Some
were identical, and therefore only 226 were analysed in
2012 and 434 in 2014. Packages with less than 2% of fat
from I-TF went up from 69 to 235, while products with
more than 2% (illegal in Denmark) went up from 197
to 408. In spite of this absolute increase in numbers, the
proportion of products with more than 2% I-TF of all
the products fulﬁlling the inclusion criteria fell from
74% to 63%.
The content of I-TF in the products in each country
was ranked according to I-TF level, expressed as grams
per 100 g of the product (ﬁgure 1). Each bar in each
panel represents a product. Only products in which
more than 2% of the fat content was I-TF are shown. For
each country, the products depicted in the panel are dif-
ferent, but the same product may appear in two or more
countries. A large increase in the number of these foods
from 2012 to 2014 was observed for each of the six coun-
tries shown in ﬁgure 1. The mean values of the percen-
tages of fat that were I-TF declined slightly in each of
the countries, mainly because of the disappearance of a
few products, with more than 40% of the fat as I-TF. In
all of the shops, there were more packages that did not
have the words partially hydrogenated fats or hydroge-
nated fats on the label than packages that had these
words on the label in 2012 as well as in 2014, which
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means that there are plenty of biscuits/cakes/wafers
without I-TF available in these supermarkets.
There is a considerable overlap of products with more
than 2% of the total fat as I-TF in the six countries in
2012 and in 2014. The numbers of unique products (ie,
products with different barcode numbers) in the six
countries, taken together in 2012 and in 2014, are
shown in ﬁgure 2 in the two upper panels. The number
of unique products increased from 136 to 248 (80%).
The mean concentration of I-TF in total fat in these pro-
ducts went down from 22.4% in 2012 to 17.6% in 2014.
The two panels in the middle of ﬁgure 2 show how, for
each of the 87 different products that fulﬁlled the inclu-
sion criteria in 2012 and 2014 and had the same barcode
ID number and the same selling name on the packages,
the amounts of I-TF in the same product have changed
during this period. The amounts of I-TF as a per cent of
total fat decreased in 59 of the packages from 2012 to
Figure 1 Amounts of industrially
produced trans fat (I-TF) in 100 g
of prepackaged biscuits/cakes/
wafers with more than 2% I-TF of
the total fat content purchased in
three supermarkets in each of the
six capitals in 2012 and again in
the same supermarkets in 2014.
Each bar in a panel represents a
unique product bought in that
capital, that is, none of the
products had the same barcode
number. N is the number of
products. X (SD) is the mean
value and the SD of the
percentages of I-TF in the total fat
of the N products.
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2014. The largest decrease was 34% points (from 40% to
6%). The mean decrease for the 59 products was 11.5
(8.5) % points. Products in three of the 87 packages had
the same per cent of I-TF in the total fat in 2012 and
2014, whereas 25 of the products had a higher per cent
of I-TF in 2014 than in 2012. The highest increase was
34% point (from 8% to 42%). The mean increase for the
25 products was 8.4 (7.8) % points. The mean value for
all 87 products taken together decreased from 23.7% to
18.3% I-TF in the total fat.
The lower panel in the 2012 column in ﬁgure 2 shows
the amounts of I-TF in products that were present in
2012 but not in 2014. Some 49 different products with
an average of 20 (13) % of I-TF in total fat were
removed between 2012 and 2014. The lower panel in
the 2014 column shows in the same way the amounts of
I-TF per 100 g product of the 156 new products in 2014
that did not appear in the supermarkets in 2012. Some
of these new products were very high in amounts of I-TF.
Producers of biscuits/cakes/wafers
The number of different producers of biscuits/cakes/
wafers with more than 2% of the total fat as I-TF
increased from 24 to 33 between 2012 and 2014. The
top 10 producers were the same in 2012 and 2014 and
together provided approximately 80% of the products in
2012 as well as in 2014 (ﬁgure 3). Table 1 show some
characteristics of the products from each of the main
producers.
The average amount of I-TF as a percentage of total fat
among the top 10 producers ranged from 4.4 (2) to 37.2
(3.8) in 2012 and from 4.2 (1.3) to 28.2 (9.8) in 2014.
Among the top 10 providers in 2012, seven used fat with
more than 30% I-TF in total fat in some of their products;
in 2014, ﬁve of the top 10 providers still used fat with more
than 30% I-TF of total fat in some of their products.
DISCUSSION
The principal finding
The ﬁndings of this study clearly demonstrate that in
2014, I-TF was still present in high concentrations in
many different brands of popular foods in each of the
six countries in South–eastern Europe, and the number
of different packages with high amounts of I-TF has
increased considerably since 2012 (ﬁgure 1). The volun-
tary reduction in the amount of I-TF in foods by food
producers appears to work well in some European coun-
tries but not—as demonstrated here—in others.7 With
altogether 23 different producers of prepackaged bis-
cuits/cakes/wafers with high amounts of I-TF in 2012
and with an increase to 33 different producers in 2014
(ﬁgure 3) and a competitive market, the possibility of an
effective voluntary reduction in I-TF is probably slim.
Figure 2 The numbers of
unique products, that is,
prepackaged biscuits/cakes/
wafers with more than 2% of the
total fat as I-TF and with different
barcode numbers, in the six
countries taken together in 2012
and in 2014 are shown in the two
upper panels. The two panels in
the middle show, for each of the
87 products that were present in
2012 and 2014 with the same
barcode ID-number, how the
amounts of I-TF in the same
product have changed from 2012
to 2014. The lower panel in the
2012 column shows the amounts
of I-TF in products that were
present in 2012 but not in 2014.
The lower panel in the 2014
column shows the 156 new
products in 2014 that did not
appear in the supermarkets in
2012. N is the number of
products. X (SD) is the mean
value and the SD of the
percentages of I-TF in the total fat
of the N products. The Y-axes in
the six panels are all equally
spaced. I-TF, industrially
produced trans fat.
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Strengths and weaknesses of the study
A strength of this study is that the same procedure to
obtain popular foods found in large supermarkets in six
European capitals in 2012 was followed in the same
supermarkets in 2014, and that the products were ana-
lysed for I-TF in the same laboratory. The study demon-
strates that I-TF is used in the prepackaged foods that
were analysed and that the presence of these foods has
increased considerably in just 2 years. I-TF was not mea-
sured in products collected in 2012 and in 2014 that did
not meet the inclusion criteria. It leaves the theoretical
possibility that more products contained I-TF in 2012
than appears from the measurements (but there is also
the possibility that more products contained I-TF in
2014 than was observed in this study). The suggestion
about an increase in the presence of foods with high
amounts of I-TF from 2012 to 2014 rests on the assump-
tion that the number of foods with appreciable amounts
of I-TF but without partially hydrogenated fat or similar
term in the list of ingredients is small in 2012 and in
2014 compared with the number of foods that fulﬁl the
inclusion criteria. The assumption seems justiﬁed, ﬁrst
of all, because it is illegal in most European countries to
omit labelling if partly hydrogenated fat is present in
prepackaged food. Many of the prepacked biscuits/
cakes/wafers on the shelves in the supermarkets in the
six countries have in the list of ingredients several other
languages such as English, German or French in add-
ition to the local language and the language of the
country of origin. This means that the products were
also meant for export. It seems unlikely that food produ-
cers would risk an export to a big market because of mis-
leading information that public food or health
authorities in any country could easily reveal.
A considerable number of products had less than 2%
of total fat as I-TF in spite of the term partly hydroge-
nated fat or similar term in the list of ingredients. This
may be due to the consideration of some food produ-
cers that a mixture of cis unsaturated fat and fully hydro-
genated fat without I-TF is understood to be partially
hydrogenated fat. An additional explanation is an effort
of the producer to empty stores of old package material
after a change of the recipe to fat without I-TF even if
the recipe is permanently changed. If the recipe only is
temporarily changed due to favourite prices for non-
hydrogenated fat, the producer may ﬁnd it better to
maintain the term partly hydrogenated fat even though
the food temporarily is without I-TF. The increase in
number of these packages, together with an increase in
number of packages containing foods with more than
2% of the fat as I-TF, suggests an increase in sale of all
biscuits/cakes/wafers. The competition of shelf space in
supermarkets is usually ﬁerce. If products do not sell,
they are rapidly replaced by other products.
It is unknown why there has been such a large
increase in the availability of these foods with high
amounts of I-TF in all of these six European countries
between 2012 and 2014. One possibility is aggressive
marketing efforts by the relatively few large producers in
these countries (ﬁgure 1). Another possibility is that the
economic downturn that all of these countries experi-
enced in 2013 and 2014 created ﬁnancial constraints
Figure 3 Number of different prepackaged biscuits/cakes/
wafers with more than 2% of the total fat as I-TF bought in
one or more of the six capitals in South-eastern Europe and
allocated to the top 10 producers designated producer A to
producer J, with producer A with the highest number of
different products (20) in 2012. For 2012, producer K
represents the sum of products from the remaining 14
producers. For 2014, producer K represents the sum of
products from the remaining 23 producers. I-TF, industrially
produced trans fat.
Table 1 Each of the top 10 producers designated
producer A to producer J with mean and maximum values
of I-TF as % of total fat for their different prepackaged
biscuits/cakes/wafers with more than 2% of total fat as
I-TF, obtained in one or more of three supermarkets in one
or more of six countries in South-eastern Europe in 2012
and again in 2014
Trans fat as % of total fat
Mean (SD) Max values
2012 2014 2012 2014
Producer A 6.4 (4.9) 8.4 (5.7) 16.8 15.7
Producer B 15.4 (5.9) 14.2 (8.4) 27.4 39.6
Producer C 37.2 (3.8) 17.6 (6.4) 42.3 29.7
Producer D 18.7 (10.1) 28.2 (9.8) 41.8 43.7
Producer E 31.4 (9.1) 17.5 (7.5) 42.7 28.3
Producer F 29.3 (7.3) 21.9 (6.4) 35.5 32.9
Producer G 31.1 (12.2) 24.5 (7.6) 44.7 34.2
Producer H 33.6 (10.8) 24.0 (2.5) 41.3 27.8
Producer I 23.2 (7.9) 12.3 (4.9) 36.8 17.4
Producer J 4.4 (2.0) 4.2 (1.3) 6.3 6.1
Producer K* 22 (11.7) 13.5 (7.9) 40.9 34.1
*For 2012, producer K represents the sum of products from the
remaining 14 producers. For 2014, producer K represents the sum
of products from the remaining 23 producers.
I-TF, industrially produced trans fat.
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and led consumer demand for cheap candy-like food
such as prepackaged biscuits/cakes/wafers to increase.
The presence of high concentrations of I-TF in bis-
cuits/cakes/wafers may be a sign that I-TF is used in
other foods as well. This is supported by the high con-
centrations recently reported in certain brands of
Serbian margarine.9 Other internationally published
reports about I-TF in other foods in these countries are
non-existent.
A limitation of this study is that no other food groups
(such as shortenings and margarines) and no unpack-
aged foods (such as baked goods, sweet rolls, pastries
and buns) were investigated. Another limitation is that
the average daily intake of I-TF was not measured in any
subgroup of the populations but instead was inferred
from the availability of popular foods with high amounts
of I-TF in large supermarkets. A relevant subgroup
would be the consumers who buy biscuits/cakes/wafers.
Voluntary reduction of I-TF in foods
Each of the top 10 producers in 2012 of biscuits/cakes/
wafers except one—producer A—has increased the
number of different foods with high I-TF in 2014 com-
pared with 2012 (ﬁgure 3). It suggests that the intake of
I-TF increased during this period. A considerable
increase or reduction in the concentration of I-TF in a
given product appeared when products obtained in
2014 were compared with products obtained in 2012
with the same barcode number and the same selling
name (ﬁgure 2, right panel in the middle). This vari-
ation suggests that the recipe for some of the products
do not require the same I-TF concentration from batch
to batch. The I-TF concentration apparently depends on
the price and availability of the fat used for the produc-
tion of the product, considerations that seem to out-
weigh the recommendation to minimise the use of I-TF
in human food. If a producer removed I-TF from a
product between 2012 and 2014 and, at the same time,
removed the term partially hydrogenated fat from the
list of ingredients, the product will not appear in
our 2014 purchase, since it did not fulﬁl the inclusion
criteria. This may explain the disappearance of at
least some of the 49 products between 2012 and 2014
(ﬁgure 2 lowest panel to the left).
When voluntary reduction of I-TF in foods does not
work, labelling of prepackaged foods with the contents
of I-TF is an alternative. This method has been used in
the USA since 2006 but will be eliminated when the new
regulation fully takes effect in 2018.5 Although labelling
prepackaged foods in Europe with I-TF content may
further reduce the mean intake of I-TF, such labelling
still allows for the intake of high amounts because
unpacked foods and foods in restaurants are not
labelled, and also because consumers might not pay
attention to or understand the labels.10 An important
advantage of a legislative limit on the I-TF content of
food is that it does not require that the population learn
about the health risks of I-TF. Furthermore, it is simpler
and less expensive to monitor the presence of I-TF in
foods at the sales level than to monitor the actual intake
of I-TF at the individual level in at-risk subgroups of the
population.
Intake of I-TF in subgroups
Certain subgroups, such as patients with severe athero-
sclerotic heart disease, have been told by their physicians
or have read in the lay press since 1994 that I-TF is bad
for the heart; many will thus avoid this type of food and
have a low intake of I-TF. This may explain the very low
TF concentrations found in the red blood cells of
patients admitted to a tertiary heart centre in Germany
between 1997 and 2001 for coronary angiography due to
chest pain or other signs of myocardial ischaemia.11 The
TF concentrations in red blood cells reﬂect the intake of
TF of only several weeks.12 Even people who accept to
be enrolled in studies concerning diet and health may
comprise a relatively health-conscious subgroup with a
low intake of I-TF.13 The low contents of TF in the blood
in health-conscious subgroups of the population thus do
not preclude the existence of other subgroups with a
much higher intake of I-TF. A recent study from 9 EU
countries reports that in spite of a low average daily
intake of TF, speciﬁc subgroups exist with average intake
values above the WHO maximum recommended level of
1 energy % of total TF.14 A vicious cycle apparently
occurs: as long as foods with high amounts of I-TF are
present in the shops, some consumers will buy them,
and as long as they are bought, the foods will be
available.
Since many of the biscuits/cakes/wafers in the 18
supermarkets that were visited and revisited in this study
did not have the words partially hydrogenated fat or
hydrogenated fat on the label, a legislative I-TF limit
would not affect the supply of these foods. Even a
one-to-one replacement of I-TF with saturated fat may
confer a health beneﬁt.15
WHO-Europe recently investigated the various ways to
reduce I-TF in foods and concluded that establishing a
legal limit for the content of I-TF in foods is potentially
the only available option that reduces the risks asso-
ciated with I-TF faced by all consumers, and doing so
may contribute to reducing inequalities. Such a policy is
unique in its combination of efﬁcacy, cost-effectiveness
and low potential for negative impact. Removing I-TF
from the food supply is possibly one of the most straight-
forward public health interventions for reducing risk of
CHD.16
I-TF legislation and CHD
Danish males and females appear to have had the
highest reduction in CHD mortality in the European
Union from 2000 to 2009.17 This was further investigated
by comparing the decline in CHD mortality in a
so-called synthetic Denmark, consisting of a composite
group of OECD countries, with the observed decline in
Denmark. The composite group simulated the observed
6 Stender S, et al. BMJ Open 2016;6:e010673. doi:10.1136/bmjopen-2015-010673
Open Access
group.bmj.com on March 16, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
decline in Denmark from 1990 to 2004, but from 2004
to 2007 the CHD mortality observed was lower than in
the synthetic Denmark, corresponding to 14.2 fewer
deaths per 100 000 inhabitants per year.18 The authors
ascribe this reduction to the Danish I-TF legislation
implemented in 2004, 3 years before the Danish anti-
smoking legislation. Owing to reports in 1994, 2001 and
2003 from the Danish Nutrition Council about the
harmful effects of I-TF in foods and subsequent media
interest, most health-conscious Danes did not consume
products with potentially high amounts of I-TF several
years before the I-TF legislation in 2004. The extra
decline in CHD mortality after the 2004 I-TF legislation
in Denmark may have been due to the effect on less
health-conscious consumers in particular and thereby
helped reduce health inequalities. This observation sup-
ports the hypothesis that healthy environments appear
to promote health more than healthy choices, as sug-
gested by a British study quantifying the socioeconomic
beneﬁts of reducing I-TF in foods.19 Findings based on
ecological data should be interpreted with care. A
change in treatment guidelines for CHD in Denmark in
2003 and 2004 was therefore scrutinised. Late in 2003,
acute PCI (percutaneous coronary intervention) was
introduced in Denmark as the recommended treatment
for acute myocardial infarct with ST-segment-elevation in
the ECG (STEMI). Patients with STEMI were trans-
ported to the nearest of ﬁve centres for acute PCI. This
plan was based on the ﬁndings that acute PCI at the
nearest heart centre was superior to ﬁbrinolysis, the
usual treatment at the local hospital.20 Although there
was a signiﬁcant reduction in the composite end point
consisting of death and reinfarction in the group from
the referral hospital receiving acute PCI compared with
the group receiving the usual ﬁbrinolytic treatment,
there was no signiﬁcant difference in coronary mortality.
After a 7.8 years follow-up period, the cumulative coron-
ary death rate in the group from the referral hospital
that received acute PCI was 12.4% versus 15.6%
(p=0.06) in the group that received ﬁbrinolysis at the
local hospital.21 The national change in treatment of
STEMI may thus have added only marginally to the
reduction in coronary death in 2004 and the following
years.
An investigation of the effect on CHD mortality of a
legislative TF limit in some counties in New York State
compared with counties that did not have this limit sug-
gests that the policy reduced the CHD mortality to the
same extent as was observed in Denmark.22
Unanswered questions and future research
It is of considerable interest if coronary mortality did
change after introduction of trans fat legislation in coun-
tries such as Iceland, Switzerland, Austria and Hungary
and if it will change in Norway, Latvia and Georgia,23
countries that more recently have introduced legislation
that restricts the use of I-TF.
If reduction of I-TF in foods reduces CHD, as seems
likely, it follows that increased I-TF in foods increases
CHD. It is of interest to discover the extent to which the
increasing intake of I-TF contributed to the increase in
CHD in the Western hemisphere from 1950 until its
peak in 1970 to 1980 and to what extent the decline in
intake of I-TF has contributed to the subsequent decline
in CHD.
Globally, CHD is still the leading cause of death in
spite of the recent decline in several countries. On the
basis of data from 2009 to 2011, there is a 10-fold differ-
ence in age-standardised mortality rates of CHD
between some countries within WHO-Europe, with
countries in Central Europe, Eastern Europe and
Central Asia having the highest rates.24 It is unknown
why, when taken together, these countries had only a
2.8% reduction in CHD mortality between 1990 and
2010, in contrast to the global reduction of 19.5% and
the more than 40% reduction in several Western
European countries during the same period.25 It seems
obvious to investigate the presence of I-TF in popular
foods in these countries with excessively high CHD
mortality.
Finally, it will be interesting to investigate the reasons
for the resistance to implementing a legal limit for I-TF
in foods in the European Union for more than 10 years
now in spite of the facts that such a legislation has
already been introduced in several European countries,
is strongly recommended by various scientiﬁc organisa-
tions, and has been found by the WHO to be the cheap-
est and most effective way to reduce CHD.26
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